All Stories

  1. The global epidemiology and health burden of the autism spectrum: findings from the Global Burden of Disease Study 2021
  2. Global, regional, and national burden of injuries, and burden attributable to injuries risk factors, 1990 to 2019: results from the Global Burden of Disease study 2019
  3. Global, regional, and national burden of HIV/AIDS, 1990–2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021
  4. The global, regional, and national burden of urolithiasis in 204 countries and territories, 2000–2021: a systematic analysis for the Global Burden of Disease Study 2021
  5. Burden of disease scenarios by state in the USA, 2022–50: a forecasting analysis for the Global Burden of Disease Study 2021
  6. Global, regional, and national progress towards the 2030 global nutrition targets and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  7. National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990–2021, and forecasts up to 2050
  8. The Global Burden of Diarrheal Diseases: Causes, Risks, and Trends (1990–2021)
  9. The burden of diseases, injuries, and risk factors by state in the USA, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  10. Global, regional, and national stillbirths at 20 weeks' gestation or longer in 204 countries and territories, 1990–2021: findings from the Global Burden of Disease Study 2021
  11. Clinical and Sociodemographic Profile, Self-Care, Adherence and Motivation for Treatment, and Satisfaction with Social Support in Portuguese Patients with Type 2 Diabetes
  12. Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  13. Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  14. Global, regional, and national burden of pulmonary arterial hypertension, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  15. European Portuguese version of the Mini-BESTest: a cross-cultural adaptation and psychometric measurements in individuals with sensorimotor impairments
  16. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050
  17. Global, regional, and national burden of upper respiratory infections and otitis media, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021
  18. Impact of phytoconstituents on oral health practices: a post COVID-19 observation
  19. Trends and levels of the global, regional, and national burden of appendicitis between 1990 and 2021: findings from the Global Burden of Disease Study 2021
  20. Publisher Correction: Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020
  21. Global estimates on the number of people blind or visually impaired by Uncorrected Refractive Error: a meta-analysis from 2000 to 2020
  22. Global estimates on the number of people blind or visually impaired by age-related macular degeneration: a meta-analysis from 2000 to 2020
  23. Global pattern, trend, and cross-country inequality of early musculoskeletal disorders from 1990 to 2019, with projection from 2020 to 2050
  24. The state of health in the European Union (EU-27) in 2019: a systematic analysis for the Global Burden of Disease study 2019
  25. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  26. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a syst...
  27. Burden of disease scenarios for 204 countries
  28. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  29. Medicinal Plant-derived Phytochemicals in Detoxification
  30. Differences between FEV6, FVC and VC at the diagnosis of obstructive ventilatory defect
  31. Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020
  32. Global Health Trends 1950–2021: Impact of COVID-19 on Mortality and Population Growth
  33. Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  34. TB Trends and WHO Goals: Global Age-Specific Analysis 1990-2021
  35. Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
  36. Development of an electrode immunosensor using carbon nanofibres-gold nanoparticles-mercaptopropionic acid-polyethylenimine for chicken liver containing colistin
  37. Literature-based screening and bibliometric analysis of the chemical composition, antioxidant and antimicrobial potential of essential oils isolated from Allium genus: 23 years of investigation
  38. Modulatory Effect of Croton heliotropiifolius Kunth Ethanolic Extract on Norfloxacin Resistance in Staphylococcus aureus
  39. Molecular Mechanisms of Anti-Inflammatory Phytochemicals 2.0
  40. Global, regional, and national mortality due to unintentional carbon monoxide poisoning, 2000–2021: results from the Global Burden of Disease Study 2021
  41. Non-edible fruit seeds: nutritional profile, clinical aspects, and enrichment in functional foods and feeds
  42. Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019
  43. The Global, Regional, and National Burden of Adult Lip, Oral, and Pharyngeal Cancer in 204 Countries and Territories
  44. NMDA Inhibitors: A Potential Contrivance to Assist in Management of Alzheimer’s Disease
  45. Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021
  46. Global, regional, and national burden of meningitis and its aetiologies, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  47. Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019
  48. The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990–2019: a systematic analysis of the Global Burden of Disease Study 2019
  49. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  50. Correction to: National and subnational burden of female and male breast cancer and risk factors in Iran from 1990 to 2019: results from the Global Burden of Disease study 2019
  51. Anticancer activity of broccoli, its organosulfur and polyphenolic compounds
  52. Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019
  53. An approach on detection, quantification, technological properties, and trends market of A2 cow milk
  54. Riparin-B as a Potential Inhibitor of AdeABC Efflux System from Acinetobacter baumannii
  55. Advances in Plants-Derived Bioactives for Cancer Treatment
  56. Incidence of Bloodstream Infection in Patients with Pulmonary Hypertension under Intravenous Epoprostenol or Iloprost—A Multicentre, Retrospective Study
  57. Pharmacological Screening of Species from the Lippia genus, Content in Terpenes and Phenylpropanoids, and their Vasorelaxing Effects on Human Umbilical Artery
  58. Plant-food-derived bioactives in managing hypertension
  59. Promising Molecular Targets in Pharmacological Therapy for Neuronal Damage in Brain Injury
  60. Naturally-occurring Bioactive Molecules with Anti-Parkinson Disease Poten
  61. Chemical Composition and Bioinsecticidal Effects of Thymus zygis L., Salvia officinalis L. and Mentha suaveolens Ehrh. Essential Oils on Medfly Ceratitis capitata and Tomato Leaf Miner Tuta absoluta
  62. Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019
  63. The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis
  64. Nocardia spp. isolation in chronic lung diseases: Are there differences between patients with pulmonary nocardiosis and Nocardia colonization?
  65. Itaconic Acid and Its Applications for Textile, Pharma and Agro-Industrial Purposes
  66. Revisiting the Nutritional, Chemical and Biological Potential of Cajanus cajan (L.) Millsp.
  67. The Neuroprotective Potential of Endophytic Fungi and Proposed Molecular Mechanism: A Current Update
  68. Molecular Mechanisms of Anti-Inflammatory Phytochemicals
  69. Anti-inflammatory and antinociceptive effect of Hyptis martiusii BENTH leaves essential oil
  70. In vivo and in silico anti-inflammatory properties of the sesquiterpene valencene
  71. Extraction Kinetics and Reaction Rates of Sacred Lotus Stamen Tea Infusion-Derived Flavonoids in Relation with Its Antioxidant Capacity
  72. Adolescent transport and unintentional injuries: a systematic analysis using the Global Burden of Disease Study 2019
  73. Bioactive Effects of Curcumin in Human Immunodeficiency Virus Infection Along
  74. The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019
  75. Electrochemical immunosensor for the detection of colistin in chicken liver
  76. Antioxidative potential of Lactobacillus sp. in ameliorating D-galactose-induced aging
  77. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020
  78. LOW PREVALENCE OF COVID-19 IN LAOS AND CAMBODIA: DOES DIET PLAY A ROLE?
  79. Caryocar coriaceum Wittm. (Caryocaraceae): Botany, Ethnomedicinal Uses, Biological Activities, Phytochemistry, Extractivism and Conservation Needs
  80. Marine Compounds with Anti-Candida sp. Activity: A Promised “Land” for New Antifungals
  81. Poisonous Plants of the Indian Himalaya: An Overview
  82. Biogenic Nanomaterials
  83. Phyto-Enrichment of Yogurt to Control Hypercholesterolemia: A Functional Approach
  84. Comparison between exercise therapy and non-hydrolyzed collagen (UC-II) in functionality and quality of life in women with knee osteoarthritis
  85. The burden of mental disorders, substance use disorders and self-harm among young people in Europe, 1990–2019: Findings from the Global Burden of Disease Study 2019
  86. Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  87. Ethnobotany, Phytochemistry and Pharmacology of Palash (Butea monosperma (Lam.) Taub.): a Systematic Review
  88. Burden of non-communicable diseases among adolescents aged 10–24 years in the EU, 1990–2019: a systematic analysis of the Global Burden of Diseases Study 2019
  89. Resveratrol’ biotechnological applications: Enlightening its antimicrobial and antioxidant properties
  90. Urtica dioica-Derived Phytochemicals for Pharmacological and Therapeutic Applications
  91. Edible mushrooms’ enrichment in food and feed: A mini review
  92. Microglia in Alzheimer’s Disease: An Unprecedented Opportunity as Prospective Drug Target
  93. Neurobiological Promises of the Bitter Diterpene Lactone Andrographolide
  94. The burden of injury in Central, Eastern, and Western European sub-region: a systematic analysis from the Global Burden of Disease 2019 Study
  95. Liquid Biopsy: the Value of Different Bodily Fluids
  96. Hyssopus Essential Oil: An Update of Its Phytochemistry, Biological Activities, and Safety Profile
  97. Biogenic Metallic Nanoparticles from Seed Extracts: Characteristics, Properties, and Applications
  98. Studies of Phytochemicals, Antioxidant, and Antibacterial Activities of Pinus gerardiana and Pinus roxburghii Seed Extracts
  99. Chemical Composition, Biological Activity, and Health-Promoting Effects of Withania somnifera for Pharma-Food Industry Applications
  100. POSSIBLE MUTATION PATHWAYS IN SARS-CoV-2
  101. Plant-Derived Alkaloids Acting on Dengue Virus and Their Vectors: From Chemistry to Pharmacology
  102. The value of cell-free circulating tumour DNA profiling in advanced non-small cell lung cancer (NSCLC) management
  103. Production, Transmission, Pathogenesis, and Control of Dengue Virus: A Literature-Based Undivided Perspective
  104. Corrigendum to Application of natural antimicrobials in food preservation: Recent views [Food Control 126 (2021) 108066]
  105. Enlightening clinical and therapeutic heterogeneity in thoracic actinomycosis: A review in bronchiectasis and non-bronchiectasis patients
  106. Recent advances in the concept of paraprobiotics: Nutraceutical/functional properties for promoting children health
  107. Paclitaxel: Application in Modern Oncology and Nanomedicine-Based Cancer Therapy
  108. Gene Therapy Approach with an Emphasis on Growth Factors: Theoretical and Clinical Outcomes in Neurodegenerative Diseases
  109. Response: Commentary: Case Report: Hyperbilirubinemia in Gilbert Syndrome Attenuates Covid-19-Induced Metabolic Disturbances
  110. Genome shuffling for phenotypic improvement of industrial strains through recursive protoplast fusion technology
  111. Paving Luteolin Therapeutic Potentialities and Agro-Food-Pharma Applications: Emphasis on In Vivo Pharmacological Effects and Bioavailability Traits
  112. Characterization and Evaluation of Layered Bi2WO6 Nanosheets as a New Antibacterial Agent
  113. Rapid diagnosis of COVID-19 in the first year of the pandemic: a systematic review
  114. Resveratrol-Based Nanoformulations as an Emerging Therapeutic Strategy for Cancer
  115. In vitro antioxidant and acetylcholinesterase inhibitory properties of the alkaloid fraction of Cissampelos sympodialis Eichler
  116. Current insights into epigenetics, noncoding RNA interactome and clinical pharmacokinetics of dietary polyphenols in cancer chemoprevention
  117. Green Synthesized Silver Nanoparticles as Potent Antifungal Agent against Aspergillus terreus Thom
  118. Bioactive Compounds as Potential Agents for Sexually Transmitted Diseases Management: A Review to Explore Molecular Mechanisms of Action
  119. Paving Plant-Food-Derived Bioactives as Effective Therapeutic Agents in Autism Spectrum Disorder
  120. Phenolic Bioactives as Antiplatelet Aggregation Factors: The Pivotal Ingredients in Maintaining Cardiovascular Health
  121. The genes road: impact of migration on newborn screening and health amid the COVID-19 pandemic in the Eastern Mediterranean region
  122. The Influence of miRNAs on Radiotherapy Treatment in Prostate Cancer – A Systematic Review
  123. Application of natural antimicrobials in food preservation: Recent views
  124. Current trends on resveratrol bioactivities to treat periodontitis
  125. MALAT1: A Promising Therapeutic Target for the Treatment of Metastatic Colorectal Cancer
  126. Role of leukotriene pathway and montelukast in pulmonary and extrapulmonary manifestations of Covid-19: The enigmatic entity
  127. The role of interventional bronchoscopy in the management of post-intubation tracheal stenosis: A 20-year experience
  128. Liquid Biopsy for Disease Monitoring in Non-Small Cell Lung Cancer: The Link between Biology and the Clinic
  129. The potential role of neopterin in Covid-19: a new perspective
  130. Management of Coronavirus Disease 2019 Patients With Lung Cancer: Experience From a Thoracic Oncology Center
  131. The Coronavirus Disease 2019 (COVID-19): Key Emphasis on Melatonin Safety and Therapeutic Efficacy
  132. Role of TREM2 in Alzheimer’s Disease: A Long Road Ahead
  133. Antimicrobial, Antioxidant and Other Pharmacological Activities of Ocimum Species: Potential to Be Used as Food Preservatives and Functional Ingredients
  134. Dairy-Derived and Egg White Proteins in Enhancing Immune System Against COVID-19
  135. Factors Behind the Higher COVID-19 Risk in Diabetes: A Critical Review
  136. Naturally Occurring Bioactives as Antivirals: Emphasis on Coronavirus Infection
  137. Chitosan nanoparticles as a promising tool in nanomedicine with particular emphasis on oncological treatment
  138. A Pharmacological Perspective on Plant-derived Bioactive Molecules for Epilepsy
  139. Applications of Fruit Polyphenols and Their Functionalized Nanoparticles Against Foodborne Bacteria: A Mini Review
  140. Dioscorea deltoidea wall. Ex Griseb: A review of traditional uses, bioactive compounds and biological activities
  141. Phytochemicals as Potential Epidrugs in Type 2 Diabetes Mellitus
  142. Clinical Application of Next-Generation Sequencing of Plasma Cell-Free DNA for Genotyping Untreated Advanced Non-Small Cell Lung Cancer
  143. Potential Usage of Edible Mushrooms and Their Residues to Retrieve Valuable Supplies for Industrial Applications
  144. COVID-19 in Relation to Hyperglycemia and Diabetes Mellitus
  145. Conifers Phytochemicals: A Valuable Forest with Therapeutic Potential
  146. Flavonoids as potential anti-platelet aggregation agents
  147. Boldness Personality Traits Are Associated With Reduced Risk Perceptions and Adoption of Protective Behaviors During the First COVID-19 Outbreak
  148. Resistance Profile of Osimertinib in Pre-treated Patients With EGFR T790M-Mutated Non-small Cell Lung Cancer
  149. Natural Products Modulating Angiotensin Converting Enzyme 2 (ACE2) as Potential COVID-19 Therapies
  150. Insights on chronic hypersensitivity pneumonitis' treatment: Factors associated with a favourable response to azathioprine
  151. Pleiotropic Effects of Tetracyclines in the Management of COVID-19: Emerging Perspectives
  152. The Role of Liquid Biopsy in Early Diagnosis of Lung Cancer
  153. Management of SARS-CoV-2 Infection: Key Focus in Macrolides Efficacy for COVID-19
  154. Curcumin and cancer biology: Focusing regulatory effects in different signalling pathways
  155. Leptospira interrogans Outer Membrane Protein-Based Nanohybrid Sensor for the Diagnosis of Leptospirosis
  156. Apigenin role as cell-signaling pathways modulator: implications in cancer prevention and treatment
  157. Concise perspectives on some synthetic thiazolidine-2,4-dione derivatives and their specific pharmacodynamic aspects
  158. Sequential doxycycline and colchicine combination therapy in Covid-19: The salutary effects
  159. The Looming Effects of Estrogen in Covid-19: A Rocky Rollout
  160. Plant Prebiotics and Their Role in the Amelioration of Diseases
  161. Interlink between pollution and COVID-19 in India: compelling view and key attributes
  162. COVID-19 Mortality and Case-Fatality Rates in Sergipe State, Northeast Brazil, From April to June 2020
  163. Modified Glasgow Prognostic Score predicts survival among advanced non-small cell lung carcinoma patients treated with anti-PD1 agents
  164. Development and antioxidant characterization of Ginger-Mint drink prepared through different extraction techniques
  165. COVID-19 and Risk of Acute Ischemic Stroke and Acute Lung Injury in Patients With Type II Diabetes Mellitus: The Anti-inflammatory Role of Metformin
  166. Case Report: Hyperbilirubinemia in Gilbert Syndrome Attenuates Covid-19-Induced Metabolic Disturbances
  167. Antioxidant potential of family Cucurbitaceae with special emphasis on Cucurbita genus: A key to alleviate oxidative stress‐mediated disorders
  168. Curcumin nanoformulations for antimicrobial and wound healing purposes
  169. Cordyceps spp.: A Review on Its Immune-Stimulatory and Other Biological Potentials
  170. Targeting androgen receptor signaling with MicroRNAs and Curcumin: a promising therapeutic approach for Prostate Cancer Prevention and intervention
  171. Hesperetin’s health potential
  172. Nanotechnology-Based Strategies for Berberine Delivery System in Cancer Treatment: Pulling Strings to Keep Berberine in Power
  173. Phytosterols: From Preclinical Evidence to Potential Clinical Applications
  174. Cyperus spp.: A Review on Phytochemical Composition, Biological Activity, and Health‐Promoting Effects
  175. Glycyrrhiza Genus: Enlightening Phytochemical Components for Pharmacological and Health‐Promoting Abilities
  176. Natural Coumarins: Exploring the Pharmacological Complexity and Underlying Molecular Mechanisms
  177. Quercetin Impact in Pancreatic Cancer: An Overview on Its Therapeutic Effects
  178. Therapeutic Potential of Isoflavones with an Emphasis on Daidzein
  179. Lasia spinosa Chemical Composition and Therapeutic Potential: A Literature‐Based Review
  180. Nano‐Derived Therapeutic Formulations with Curcumin in Inflammation‐Related Diseases
  181. Obesity and gut microbiome: review of potential role of probiotics
  182. Astragalus species: Insights on its chemical composition toward pharmacological applications
  183. Quercetin acts as a P-gp modulator via impeding signal transduction from nucleotide-binding domain to transmembrane domain
  184. Adjunct use of honey in diabetes mellitus: A consensus or conundrum?
  185. A rare case of pulmonary disease combining alpha-1-antitrypsin deficiency and common variable immunodeficiency
  186. Ethnopharmacology, Phytochemistry and Biological Activities of Native Chilean Plants
  187. Trends in MERS-CoV, SARS-CoV, and SARS-CoV-2 (COVID-19) Diagnosis Strategies: A Patent Review
  188. Neuroprotective potential of Myrica esulenta in Haloperidol induced Parkinson’s disease
  189. Severe asthma intervention in adult obese patients
  190. Mushrooms-Rich Preparations on Wound Healing: From Nutritional to Medicinal Attributes
  191. Turmeric and Its Major Compound Curcumin on Health: Bioactive Effects and Safety Profiles for Food, Pharmaceutical, Biotechnological and Medicinal Applications
  192. Pulmonary Fibrosis Secondary to Oxaliplatin Treatment: From Rarity to Reality: A Case Study and Literature Review
  193. Limonene, a food additive, and its active metabolite perillyl alcohol improve regeneration and attenuate neuropathic pain after peripheral nerve injury: Evidence for IL-1β, TNF-α, GAP, NGF and ERK involvement
  194. Probiotics: Versatile Bioactive Components in Promoting Human Health
  195. Telomeres, DNA Damage and Ageing: Potential Leads from Ayurvedic Rasayana (Anti-Ageing) Drugs
  196. Myricetin bioactive effects: moving from preclinical evidence to potential clinical applications
  197. An Upcoming Approach to Alzheimer's Disease: Ethnopharmacological Potential of Plant Bioactive Molecules
  198. Ocotea glomerata (Nees) Mez Extract and Fractions: Chemical Characterization, Anti-Candida Activity and Related Mechanism of Action
  199. Structural, Vibrational and Electrochemical Analysis and Antibacterial Potential of Isomeric Chalcones Derived from Natural Acetophenone
  200. Lifestyle, Oxidative Stress, and Antioxidants: Back and Forth in the Pathophysiology of Chronic Diseases
  201. Achillea spp.: A comprehensive review on its ethnobotany, phytochemistry, phytopharmacology and industrial applications
  202. Biological activities and health-promoting effects of Pyracantha genus: a key approach to the phytochemical's potential
  203. Antitumor effects of citrinin in an animal model of Sarcoma 180 via cytogenetic mechanisms
  204. Anxiolytic-like effects of Moringa oleifera in Swiss mice
  205. Ascorbic acid antagonizes the sedative effect of diazepam possibly through inhibition of GABA(Aρ₁) and GABA(B1) receptors
  206. Bio-therapeutics effects of probiotic strain on the gastrointestinal health of severely acute malnourished children
  207. Biological activities of sinularin: A literature-based review
  208. Effects of galacto-oligosaccharide prebiotics in blood profile of severely acute malnourished children
  209. Insights on the anticancer potential of plant-food bioactives: A key focus to prostate cancer
  210. Palmatine antioxidant and anti-acetylcholinesterase activities: A pre-clinical assessment
  211. Phenolic compounds, saponins and alkaloids on cancer progression: emphasis on p53 expression and telomere length
  212. Phytol anti-inflammatory activity: Pre-clinical assessment and possible mechanism of action elucidation
  213. Plant-food-derived bioactives: Key health benefits and current nanosystems as a strategy to enhance their bioavailability
  214. Vitex negundo Linn.: phytochemical composition, nutritional analysis, and antioxidant and antimicrobial activity
  215. p-Cymene metallo-derivatives: An overview on anticancer activity
  216. Chalcones Isolated from Arrabidaea brachypoda Flowers as Inhibitors of NorA and MepA Multidrug Efflux Pumps of Staphylococcus aureus
  217. In Vitro Toxicity, Antioxidant, Anti-Inflammatory, and Antidiabetic Potential of Sphaerostephanos unitus (L.) Holttum
  218. Antioxidant, Antimicrobial, and Anticancer Effects of Anacardium Plants: An Ethnopharmacological Perspective
  219. Organochlorine pesticide residues in raw milk samples collected from dairy farms and urban areas of Lahore district, Pakistan
  220. Therapeutic Potential of Quercetin: New Insights and Perspectives for Human Health
  221. RETRACTED ARTICLE: Human microbiome and homeostasis: insights into the key role of prebiotics, probiotics, and symbiotics
  222. Hypersensitivity pneumonitis: Main features characterization in a Portuguese cohort
  223. Evaluation of the Antibacterial Activity and Efflux Pump Reversal of Thymol and Carvacrol against Staphylococcus aureus and Their Toxicity in Drosophila melanogaster
  224. Influence of Family Environment and Tobacco Addiction: A Short Report from a Post-Graduate Teaching Hospital, India
  225. Role of Vacha (Acorus calamus Linn.) in Neurological and Metabolic Disorders: Evidence from Ethnopharmacology, Phytochemistry, Pharmacology and Clinical Study
  226. Impact of Natural Compounds on Neurodegenerative Disorders: From Preclinical to Pharmacotherapeutics
  227. Mercury-induced autoimmunity: Drifting from micro to macro concerns on autoimmune disorders
  228. Diet, Lifestyle and Cardiovascular Diseases: Linking Pathophysiology to Cardioprotective Effects of Natural Bioactive Compounds
  229. Therapeutic Applications of Curcumin Nanomedicine Formulations in Cardiovascular Diseases
  230. Biomaterial-Related Infections
  231. Management of Streptococcus mutans-Candida spp. Oral Biofilms’ Infections: Paving the Way for Effective Clinical Interventions
  232. Rosmarinus plants: Key farm concepts towards food applications
  233. Curcumin’s Nanomedicine Formulations for Therapeutic Application in Neurological Diseases
  234. Plant-Derived Bioactives and Oxidative Stress-Related Disorders: A Key Trend towards Healthy Aging and Longevity Promotion
  235. Impact of Azathioprine use in chronic hypersensitivity pneumonitis patients
  236. Avocado–Soybean Unsaponifiables: A Panoply of Potentialities to Be Exploited
  237. Nanoencapsulation of Anthocyanins for Drug Delivery Systems
  238. Effects of an Educational Intervention on Angolan Adolescents’ Knowledge of Human Reproduction: A Quasi-Experimental Study
  239. Therapeutic Potential of Allicin-Rich Garlic Preparations: Emphasis on Clinical Evidence toward Upcoming Drugs Formulation
  240. Highlighting medicinal plants toward biomolecules discovery for upcoming drugs formulation
  241. Prosopis Plant Chemical Composition and Pharmacological Attributes: Targeting Clinical Studies from Preclinical Evidence
  242. Liposomal Cytarabine as Cancer Therapy: From Chemistry to Medicine
  243. Current Trends on Seaweeds: Looking at Chemical Composition, Phytopharmacology, and Cosmetic Applications
  244. Therapeutic Potential of α- and β-Pinene: A Miracle Gift of Nature
  245. Convolvulus plant—A comprehensive review from phytochemical composition to pharmacy
  246. Malva species: Insights on its chemical composition towards pharmacological applications
  247. Natural Products and Synthetic Analogs as a Source of Antitumor Drugs
  248. Upper Airway Video Endoscopy: Assessment of the response to positive pressure ventilation and mechanical in-exsufflation
  249. Anacardium Plants: Chemical,Nutritional Composition and Biotechnological Applications
  250. Insights into Eucalyptus genus chemical constituents, biological activities and health-promoting effects
  251. Phenolic Plant Extracts Versus Penicillin G: In Vitro Susceptibility of Staphylococcus aureus Isolated from Bovine Mastitis
  252. Apium Plants: Beyond Simple Food and Phytopharmacological Applications
  253. Role of Bronchoscopic Techniques in the Diagnosis of Thoracic Sarcoidosis
  254. Targeted Gene Next-Generation Sequencing Panel in Patients with Advanced Lung Adenocarcinoma: Paving the Way for Clinical Implementation
  255. Stevia rebaudiana Bertoni bioactive effects: From in vivo to clinical trials towards future therapeutic approaches
  256. Cucurbita Plants: From Farm to Industry
  257. Silymarin antiproliferative and apoptotic effects: Insights into its clinical impact in various types of cancer
  258. Insights on the Use of α-Lipoic Acid for Therapeutic Purposes
  259. Phytochemical Composition, Antioxidant, and Antimicrobial Attributes of Different Solvent Extracts from Myrica esculenta Buch.-Ham. ex. D. Don Leaves
  260. Therapeutic Potential of Rosmarinic Acid: A Comprehensive Review
  261. Lavandula Luisieri and Lavandula Viridis Essential Oils as Upcoming Anti-Protozoal Agents: A Key Focus on Leishmaniasis
  262. Melatonin in Medicinal and Food Plants: Occurrence, Bioavailability, and Health Potential for Humans
  263. Veronica Plants—Drifting from Farm to Traditional Healing, Food Application, and Phytopharmacology
  264. Phytochemicals in Prostate Cancer: From Bioactive Molecules to Upcoming Therapeutic Agents
  265. Kaempferol: A Key Emphasis to Its Anticancer Potential
  266. Symphytum Species: A Comprehensive Review on Chemical Composition, Food Applications and Phytopharmacology
  267. Plants of the genus Spinacia: From bioactive molecules to food and phytopharmacological applications
  268. Myrica esculenta Buch.-Ham. ex D. Don: A Natural Source for Health Promotion and Disease Prevention
  269. Cucurbits Plants: A Key Emphasis to Its Pharmacological Potential
  270. Advances in Chemical and Biological Methods to Identify Microorganisms—From Past to Present
  271. Anti-biofilm activity of hydromethanolic plant extracts against Staphylococcus aureus isolates from bovine mastitis
  272. Chyawanprash: A Traditional Indian Bioactive Health Supplement
  273. Synergistic Effects of Plant Derivatives and Conventional Chemotherapeutic Agents: An Update on the Cancer Perspective
  274. Allicin and health: A comprehensive review
  275. Plant-Derived Bioactives in Oral Mucosal Lesions: A Key Emphasis to Curcumin, Lycopene, Chamomile, Aloe vera, Green Tea and Coffee Properties
  276. The Therapeutic Potential of Apigenin
  277. Measurement of Off-Flavoring Volatile Compounds and Microbial Load as a Probable Marker for Keeping Quality of Pasteurized Milk
  278. Chronic Bacterial Infection Prevalence, Risk Factors, and Characteristics: A Bronchiectasis Population-Based Prospective Study
  279. Hypersensitivity pneumonitis: Antigen diversity and disease implications
  280. The therapeutic potential of curcumin: A review of clinical trials
  281. Understanding Camellia sinensis using Omics Technologies along with Endophytic Bacteria and Environmental Roles on Metabolism: A Review
  282. The Therapeutic Potential of Naringenin: A Review of Clinical Trials
  283. Beneficial Effects and Potential Risks Of Tomatoes Consumption For Human Health: An Overview
  284. Novel Therapies for Biofilm-Based Candida spp. Infections
  285. Epibatidine: A Promising Natural Alkaloid in Health
  286. Looking at Marine-Derived Bioactive Molecules as Upcoming Anti-Diabetic Agents: A Special Emphasis on PTP1B Inhibitors
  287. Endobronchial Ultrasound under Moderate Sedation versus General Anesthesia
  288. Antioxidants: Positive or Negative Actors?
  289. Functional and Endoscopic Indicators for Percutaneous Endoscopic Gastrostomy (PEG) in Amyotrophic Lateral Sclerosis Patients
  290. Aloe Genus Plants: From Farm to Food Applications and Phytopharmacotherapy
  291. Resveratrol: A Double-Edged Sword in Health Benefits
  292. Plants of Genus Mentha: From Farm to Food Factory
  293. Phytochemicals in Helicobacter pylori Infections: What Are We Doing Now?
  294. Antiulcer Agents: From Plant Extracts to Phytochemicals in Healing Promotion
  295. Edible halophytes of the Mediterranean basin: Potential candidates for novel food products
  296. Halophytic herbs of the Mediterranean basin: An alternative approach to health
  297. Brief Challenges on Medicinal Plants: An Eye‐Opening Look at Ageing‐Related Disorders
  298. Assessment of the nitrogen fertilization effect on bioactive compounds of frozen fresh and dried samples of Stevia rebaudiana Bertoni
  299. Plant phenolic extracts as an effective strategy to control Staphylococcus aureus , the dairy industry pathogen
  300. Susceptibility testing of Candida albicans and Candida glabrata to Glycyrrhiza glabra L.
  301. Development of Functional Dairy Foods
  302. Mountain food products: A broad spectrum of market potential to be exploited
  303. Wastes and by-products: Upcoming sources of carotenoids for biotechnological purposes and health-related applications
  304. Coloring attributes of betalains: a key emphasis on stability and future applications
  305. Contribution of the phenolic composition to the antioxidant, anti-inflammatory and antitumor potential of Equisetum giganteum L. and Tilia platyphyllos Scop.
  306. Neurocognitive Improvement Through Plant Food Bioactives: A Particular Approach to Alzheimer’s Disease
  307. Phenolic Compounds and Its Bioavailability
  308. Phytochemical composition, health effects, and crop management of liquorice (Glycyrrhiza glabra L.): Α medicinal plant
  309. Introduction
  310. Chemical composition and bioactive compounds of garlic (Allium sativum L.) as affected by pre- and post-harvest conditions: A review
  311. Bioactive properties and functional constituents of Hypericum androsaemum L.: A focus on the phenolic profile
  312. Phytochemical composition and bioactive compounds of common purslane ( Portulaca oleracea L.) as affected by crop management practices
  313. Phytopharmacologic preparations as predictors of plant bioactivity: A particular approach to Echinacea purpurea (L.) Moench antioxidant properties
  314. Food colorants: Challenges, opportunities and current desires of agro-industries to ensure consumer expectations and regulatory practices
  315. In vitro anti-Candida activity of Glycyrrhiza glabra L.
  316. In vivo antioxidant activity of phenolic compounds: Facts and gaps
  317. Antioxidant potential of two Apiaceae plant extracts: A comparative study focused on the phenolic composition
  318. Activity of phenolic compounds from plant origin against Candida species
  319. Plants used in folk medicine: The potential of their hydromethanolic extracts against Candida species
  320. Evaluation of bioactive properties and phenolic compounds in different extracts prepared from Salvia officinalis L.
  321. Characterization of phenolic compounds and antioxidant properties of Glycyrrhiza glabra L. rhizomes and roots
  322. Decoction, infusion and hydroalcoholic extract of cultivated thyme: Antioxidant and antibacterial activities, and phenolic characterisation
  323. In VivoAnti-CandidaActivity of Phenolic Extracts and Compounds: Future Perspectives Focusing on Effective Clinical Interventions
  324. Antifungal activity against Candida species and phenolic characterization of decoction, infusion and hydroalcoholic extract of cultivated Salvia officinalis L.
  325. Decoction, infusion and hydroalcoholic extract of Origanum vulgare L.: Different performances regarding bioactivity and phenolic compounds
  326. Candidiasis: Predisposing Factors, Prevention, Diagnosis and Alternative Treatment